Dr. Krishna Anurag Pulumati, MD

Dr. Pulumati practices at Chaparral Medical Group, Inc. in Pomona, California.

Dr. Pulumati's NPI, 1982044244, was assigned on July 1, 2013. Dr. Pulumati graduated from Other in 2009. Dr. Pulumati holds California license A156749.

Dr. Pulumati's primary practice is Chaparral Medical Group, Inc., at 1866 N Orange Grove Ave, Pomona, CA 91767 in Los Angeles County. The practice phone is (909) 623-8796.

Dr. Pulumati's primary practice is Chaparral Medical Group, Inc. in Pomona, California. Dr. Pulumati is also affiliated with Pomona Valley Hospital Medical Center. The medical group on file is Chaparral Medical Group. Dmand AI also links Dr. Pulumati to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pulumati practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Pulumati's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Pulumati is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Pulumati is licensed in California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage and heart bypass surgery among the conditions Dr. Pulumati treats.

CMS data shows 1,065 Medicare services from Dr. Pulumati across 19 procedure codes in 2024, for 393 Medicare patients. Medicare paid $104,143 for them.

CMS counts 393 Medicare patients who saw Dr. Pulumati in 2024. The largest group is 75 to 84, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pulumati's median patient age at 68, with 48% women.

In 2024, Dr. Pulumati wrote 4,277 Medicare Part D claims for 548 patients. 82% of them were for generic drugs. CMS names the drug for 4,082 of them, across 36 drugs with 11 or more claims each, at $760,907 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Pulumati for performance year 2024, reported as part of a group. Dr. Pulumati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pulumati as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 35 general payments to Dr. Pulumati from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $300.

Dr. Pulumati graduated from Other in 2009.

Dr. Pulumati is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.